Gains and losses of HLA class II (DR) and CD4 in atypical hyperplasia, carcinoma in situ and infiltrating ductal carcinoma of the breast.

Acta medica (Hradec Králové) / Universitas Carolina, Facultas Medica Hradec Králové

Volumn 47, Issue 4, 2004, Pages 257-262

  Tamiolakisl, Demetrio ^a   Venizelos, Ioannis ^a   Lambropoulou, Maria ^a   Jivannakis, Theodoros ^a   Seliniotakis, Evagelia ^a   Tsikouras, Panagiotis ^a   Limberis, Vasilios ^a   Tsalkidis, Angelos ^a   Papadopoulos, Nikolas ^a  

^a General Hospital of Chania

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; BREAST; BREAST TUMOR; CD4 LYMPHOCYTE COUNT; FEMALE; HUMAN; HYPERPLASIA; IMMUNOLOGY; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD4; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CD4 LYMPHOCYTE COUNT; FEMALE; HLA-DR ANTIGENS; HUMANS; HYPERPLASIA; MIDDLE AGED;

MLCS; MLOWN;

EID: 18244382822     PISSN: 12114286     EISSN: None     Source Type: Journal    
DOI: 10.14712/18059694.2018.101     Document Type: Article

References (0)